Výsledky vyhledávání - "A.L.A. Kuijpers"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry

Autor: J.M.P.A. van den Reek, P.M. Ossenkoppele, J.M.M. Groenewoud, M.D. Njoo, M.P.M. Andriessen, P.C.M. van de Kerkhof, P.P.M. van Lümig, R.J.B. Driessen, W.P. Arnold, J.M. Mommers, Jeffrey Zweegers, M.A.M. Berends, M.I.A. Koetsier, M.E. Otero, Wietske Kievit, E.M.G.J. de Jong, A.L.A. Kuijpers

Publikováno v: British Journal of Dermatology, 176, 4, pp. 1001-1009
British Journal of Dermatology, 176, 1001-1009

Contains fulltext : 174191.pdf (Publisher’s version ) (Closed access) BACKGROUND: The efficacy of etanercept and ustekinumab in psoriasis has been compared in one randomized controlled trial. Comparison of the long-term effectiveness of biologics i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac4ae5d0bd115d5b814fe1ad0ad9b305
https://doi.org/10.1111/bjd.15023

Zobrazit plný text záznamu

'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network

Autor: M.E. Otero, J.M.P.A. van den Reek, Jeffrey Zweegers, P.M. Ossenkoppele, Marieke M B Seyger, B.A.M. Sybrandy-Fleuren, R.J.B. Driessen, M.D. Njoo, M.P.M. Andriessen, W.P. Arnold, M.I.A. Koetsier, P.C.M. van de Kerkhof, P.P.M. van Lümig, Wietske Kievit, J.M. Mommers, E.M.G.J. de Jong, A.L.A. Kuijpers

Publikováno v: British Journal of Dermatology, 171, 5, pp. 1189-96
British Journal of Dermatology, 171, 1189-96

Contains fulltext : 137707.pdf (Publisher’s version ) (Closed access) BACKGROUND: Drug survival is a marker for treatment success. To date, no analyses relating dermatological quality-of-life measures to drug survival have been published. OBJECTIVE

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca98e86b40060f4f3a92f74d3f0ed5df
https://hdl.handle.net/2066/137707

Zobrazit plný text záznamu

Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry

Autor: P.M. Ossenkoppele, P.C.M. van de Kerkhof, P.P.M. van Lümig, Jeffrey Zweegers, Wietske Kievit, M.E. Otero, M.A.M. Berends, E.M.G.J. de Jong, R.J.B. Driessen, M.I.A. Koetsier, J.M.P.A. van den Reek, W.P. Arnold, A.L.A. Kuijpers, M.D. Njoo, L. Weppner-Parren, J.M. Mommers

Publikováno v: British Journal of Dermatology, 175, 340-7
British Journal of Dermatology, 175, 2, pp. 340-7

Contains fulltext : 172038.pdf (Publisher’s version ) (Closed access) BACKGROUND: Predictors for successful treatment are important for personalized medicine. Predictors for drug survival of biologics in psoriasis have been assessed, but not split

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c04ebc7027ca3dc9c144ad0af02f6b6
https://pubmed.ncbi.nlm.nih.gov/27535601

Zobrazit plný text záznamu

SKALP/elafin gene polymorphisms are not associated with pustular forms of psoriasis

Autor: P.C.M. van de Kerkhof, H. O. F. Molhuizen, Edwin C. M. Mariman, Patrick L.J.M. Zeeuwen, Rolph Pfundt, A.L.A. Kuijpers, J. Schalkwijk

Publikováno v: Clinical Genetics, 54, pp. 96-101
Clinical Genetics, 54, 96-101

Psoriasis is a multifactorial skin disease characterised by epidermal abnormalities and infiltration by lymphocytes and polymorphonuclear leukocytes (PMN). Skin-derived antileukoproteinase (SKALP), also known as elafin, is a potent inhibitor of human

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53adda20a71170a60ffe7af6e2ff79cf
https://doi.org/10.1111/j.1399-0004.1998.tb03703.x

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: BioCAPTURE

Autor: A.L.A. Kuijpers, Jeffrey Zweegers, Wietske Kievit, J.M. Mommers, M.P.M. Andriessen, M.I.A. Koetsier, E.M.G.J. de Jong, P.C.M. van de Kerkhof, M.D. Njoo, M.E. Otero, J.M.P.A. van den Reek, W.P. Arnold, B.A.M. Sybrandy-Fleuren, P.M. Ossenkoppele

Publikováno v: British Journal of Dermatology, 171, 5, pp. 1091-8
British Journal of Dermatology, 171, 1091-8

Contains fulltext : 137672.pdf (Publisher’s version ) (Closed access) BACKGROUND: Treatment goals have been developed to optimize daily clinical practice psoriasis care, but have not yet been studied in real life. OBJECTIVES: To investigate to what

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3b8b54b19f5ad175e034efcb1472ce1
https://hdl.handle.net/2066/137672

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Risk-Benefit Assessment of Methotrexate in the Treatment of Severe Psoriasis

Autor: Peter C.M. van de Kerkhof, A.L.A. Kuijpers

Publikováno v: American Journal of Clinical Dermatology. 1:27-39

Methotrexate is an established and highly effective systemic treatment for severe psoriasis, including the pustular and erythrodermic forms. It has been widely used during the last 3 decades. For this reason, the long term adverse effects of methotre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::210507833d6dad14911ec6b42639dd98
https://doi.org/10.2165/00128071-200001010-00003

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání